ask="N/A"
ask_size="N/A"
average_daily_volume="363777"
bid="30.59"
bid_size="400"
book_value="6.19"
change="-0.61"
change_from_200_day_moving_average="0.23"
change_from_50_day_moving_average="-0.78"
change_from_52_week_high="-8.29"
change_From_52_week_low="17.04"
change_in_percent="-1.95%"
close="30.63"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="31.30"
high_52_weeks="38.92"
last_trade_date="2/7/2017"
last_trade_price="30.63"
last_trade_size="10706"
last_trade_time="4:00pm"
low="30.12"
low_52_weeks="13.59"
market_capitalization="1.59B"
moving_average_200_day="30.40"
moving_average_50_day="31.41"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="31.30"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+0.76%"
percent_change_from_50_day_moving_average="-2.49%"
percent_change_from_52_week_high="-21.30%"
percent_change_from_52_week_low="+125.39%"
previous_close="31.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.04"
price_per_sales="34.64"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="18.07"
stock_exchange="NGM"
symbol="TBPH"
volume="158117"
weeks_range_52="13.59 - 38.92"
